SV7 Growth Fund Strategic Partners, L.P.
Late investment periodEmerging manager
Late investment period: no first sale reported; age from Form D filed Apr 2022 (approximate)
No contact route found yet.
- Vintage
- Unknown
- Fund size
- $9.39M (SEC adviser filing)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices, Healthtech
- Regions
- Global
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$94K to $157K (estimated from fund size)
Estimated from SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- Thomas Flynn, Managing Member of the General Partner
- Michael Balmuth, Managing Member of the General Partner
- Eugene Hill
- Greg Madden
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideSV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors through strategy-specific funds.
SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors through strategy-specific funds.
https://svhealthinvestors.com/strategy
06 · Sources
Last verified: Oct 28, 2026